Skip to content

Education Against Tobacco Randomized Trial in Bosnia and Herzegovina

Education Against Tobacco: Medical-student-delivered Smoking Prevention Programme for Secondary Schools in Bosnia and Herzegovina - Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02731547
Enrollment
1500
Registered
2016-04-07
Start date
2016-05-31
Completion date
Unknown
Last updated
2016-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schools, Tobacco, Tobacco Prevention

Brief summary

A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary schools in Bosnia and Herzegovina. The primary endpoint is the change in smoking prevalence between the two groups.

Interventions

BEHAVIORALEducation Against Tobacco School-Based Intervention

Sponsors

University of Dhaka
CollaboratorOTHER
University of Giessen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

Visiting grades 7-9 of regular secondary schools in Bosnia and Herzegovina.

Exclusion criteria

Not fulfilling inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Smoking prevalence measured via questionnaire.12 months follow-up

Secondary

MeasureTime frameDescription
Smoking onset: Difference in the number of new smokers at 12 months of follow-up who were not present at baselineBaseline and 12 months
Difference in the number of new non-smokers at 12 months of follow-up who were smoking at baselineBaseline and 12 months
Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire.Baseline and 12 monthsDifference in attitude towards smoking between the two groups at 12 months follow-up measured via questionnaires.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026